Introduction The implantation of intraocular lenses (IOLs) following removal of a cataractous crystalline lens is one of the most common surgical procedures performed in the United States. From an ...

PUNE, India, August 16, 2017 /PRNewswire/ --Intraocular Lens (IOLs) market report outlines the evolution of Intraocular Lens (IOLs) market by type ...

Two new studies on presbyopia-correcting intraocular lenses (PC-IOLs) highlight the need for individualized patient management, including careful patient selection and good physician/patient ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available in select ...

--Johnson& Johnson§, a global leader in eye health, has announced it's expanding the roll-out of its latest advancement in presbyopia-correcting intraocular lenses, TECNIS Odyssey, in the U.S.

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Swiss Advanced Vision (SAV-IOL) has announced the launch of Project R-TASC, set to disrupt the global intraocular lens (IOL) market. Cataracts are ...

LONDON, Jan. 22, 2018 /PRNewswire/ -- Intraocular Lens (IOL) Market Analysis By Product (Monofocal, Multifocal, Toric, and Accommodative), By End User, By Region, And Segment Forecasts, 2014 ...

In March 2025, Alcon announced that Vivity, the most widely implanted extended depth of focus (EDOF) intraocular lens (IOL), is now available using its latest lens material, Clareon.

RxSight has commercialized the first and only FDA approved customizable intraocular lens. The Company closed an IPO recently with gross proceeds of $132 million. Analysts are very bullish with the ...